Axios @axios
.@Harvardmed Professor @Ateevm on eliminating rebates to lower drug pricing: “In the background there’s a lot of money transferring hands between the insurance companies and the pharmaceutical industry. Those rebates are problematic…it's really corrupting our current process.” — PolitiTweet.org
